Monday, 19 April 2021

Tutorial 19 April 2021

 Contact us.


Website.

 

44.

EMQ. Montgomery ruling

45.

Role-play. BRCA1 carrier. Risk reduction.

46.

Viva. Enhanced recovery

47.

EMQ. Warfarin & pregnancy

48.

EMQ. Pertussis

 

44.         EMQ. Montgomery ruling.

Abbreviations.

BMA:       British Medical Association.

GMC:       General Medical Council.

MR:         Montgomery Ruling.

Question 1.             

Which, if any, of the following statements is most accurate?

Lead-in

A

The MR largely replaces the Bolam ruling

B

The MR largely replaces the Chester ruling

C

The MR largely replaces the Sidaway ruling

D

The MR is being contested in the European Court by the GMC as it infringes doctors’ rights

E

The MR is being contested in the European Court by the BMA as it infringes doctors’ rights

Question 2.             

Which, if any, of the following statements are true? This is not a true EMQ as > 1 of the answers may be correct.

Lead-in

A

the level of risk, however small, must be disclosed if a patient requests it

B

the level of risk of damage from a procedure need not be disclosed if < 1%

C

the level of risk of damage from a procedure need not be disclosed if < 10%

D

a material risk is one that would be reflected in damages > £100,000 if negligence were proved in court

E

a material risk is one that would be reflected in damages > £1,000,000 if negligence were proved in court

F

a material risk is one that involves anatomical damage, not emotional or psychological

G

a material risk is one that a reasonable person in the patient’s situation would be likely to regards as significant

 

45.         Role-play. BRCA. Risk reduction.

Candidate’s instructions.

You are an SpR5 in the gynaecology clinic and about to see Jessica Green. DOB 1 January 1990. Your tasks are to take an appropriate history and discuss the options available to her.

GP letter.

The Surgery,

Main Road, Anytown.

Re: Jessica Green, 25 Blether Alley, Anytown.

Dear Gynaecologist,

Please see this charming young lady. Dr. Rosemary Ique,  my very clever young colleague, saw her last year to discuss management of anaemia and heavy periods. There was good response to the use of a Mirena and some iron pills, but clever Dr. Rosemary elicited a family history of cancer and referred her to the regional Familial Genetic Cancer clinic and it turns out that she is a carrier of an oncogenic BRCA mutation. All of this is quite new to me, I must say, and I suspect that I might not have sparked to the importance of the family history, or even uncovered it! There was some discussion of her options to reduce her risk of cancer and she would very much like to explore these further. I look forward to hearing your thoughts.

Dr. John Worthy.

 

46.         Structured conversation. Enhanced recovery.

Candidate's instructions.

You are a newly-appointed consultant. The Clinical Director has asked you to develop a programme for enhanced recovery for inpatient gynaecological surgery. As a first step, she has asked you to deliver a talk to a unit meeting (all staff can attend) to outline the key features of enhanced recovery. She suspects that little is known about the subject by most of the staff and hopes that your talk will encourage their enthusiastic participation. The examiner will ask you 9 questions pertinent to your talk.

 

47.         EMQ. Warfarin and pregnancy.

Some of the questions are not true EMQs as there may be > 1 correct answer – it saves typing.

Scenario 1.              

Which of the following describe the drug category that includes warfarin?

Option list.

A

anticoagulant

B

biologic

C

coumarin

D

direct-acting oral anticoagulant

E

diuretic

F

immunomodulator

G

parenteral anticoagulant

H

platelet inhibitor

I

vitamin K derived clotting factor inhibitor

J

none of the above

Scenario 2.              

How does warfarin produce its anticoagulant effect? Which, if any, of the following are true?

Option list.

A

levels of Protein C

B

levels of Protein S

C

levels of Factor I

D

levels of Factor II

E

levels of Factor III

F

levels of Factor IV

G

levels of Factor V

H

levels of Factor VI

I

levels of Factor VII

J

levels of Factor VIII

K

levels of Factor IX

L

levels of Factor X

Scenario 3.              

Which of the following is used to monitor the effect of warfarin?

Option list.

A

bleeding time

B

clotting time

C

factor IXa levels

D

factor Xa levels

E

international normalised ratio

F

platelet levels

Scenario 4.              

What are the main teratogenic effects of warfarin taken in the 1st. trimester?

There is no option list to make things harder – just write out what you know about the teratogenic effects.

Scenario 5.              

Which, if any, of the following statements are true in relation to the risk of warfarin?

Option list.

A

warfarin embryopathy is most likely if the drug is taken between 4 and 10 weeks

B

warfarin embryopathy is most likely if the drug is taken between 6 and 12 weeks

C

the cut-off dose for high and low risk of warfarin embryopathy is 3 mg. in the 1st. trimester

D

the cut-off dose for high and low risk of warfarin embryopathy is 5 mg. in the 1st. trimester

E

the cut-off dose for high and low risk of warfarin embryopathy is 7.5 mg. in the 1st. trimester

Scenario 6.              

What is the approximate risk of warfarin embryopathy if the drug is taken at the time of greatest risk in the 1st. trimester?

Option list.

A

1%

B

2.5%

C

5%

D

7.5%

E

10%

Scenario 7.              

Which of the following adverse outcomes are associated with warfarin use in pregnancy?

Option list.

Option list.

A

risk of APH

B

microcephaly

C

risk of miscarriage

D

risk of PPH

E

risk of stillbirth

Scenario 8.              

Which, if any, of the following statements are true in relation to warfarin and breastfeeding?

Option list.

A

Warfarin is contraindicated because of the risk of neonatal intracranial haemorrhage

B

Warfarin is contraindicated because of the risk of PPH

C

Warfarin is contraindicated because of its variable effects on neonatal coagulation

D

Warfarin is highly bound to plasma proteins

E

Warfarin is not contraindicated as insufficient transfers to breast milk to be a hazard to the neonate

Scenario 9.              

What should be your ‘knee-jerk’ response to a question asking which is the one condition for which warfarin is indicated in pregnancy?

 

48.         SBA. Pertussis.

Question  1.      

Lead-in. Why is pertussis of current concern in obstetrics?

Option List

A

Research has linked pertussis in the 1st. trimester with an risk of congenital heart disease

B

A mini-epidemic since 2011 has caused deaths of mothers & of babies < 3 months

C

A mini-epidemic since 2011 has caused deaths of babies < 3 months

D

The infecting organism has become increasingly drug-resistant

E

The infecting organism has become increasingly virulent

Question  2.      

Lead-in

Which organism causes whooping cough?

Option List

A

Bordella pertussis

B

Bacteroides pertussis

C

Rotavirus whoopoe

D

Respiratory syncytiovirus pertussis

E

None of the above

Question  3.      

Lead-in

Which, if any, of the following statements is true about the organism what causes whooping cough? This is not a true SBA as I have condensed several questions into one to save space, there are more than 5 options and there may be more than one correct answer.

Option List

A

the organism is aerobic

B

the organism is anaerobic

C

the organism is capsulated

D

the organism is flagellate

E

the organism is an obligate intra-cellular parasite

F

the organism is a Gram -ve diplococcus

G

the organism is a Gram +ve diplococcus

H

the organism requires special transport media

I

no one is going to ask me any of this stuff

 

 

 

 

 

 

 

 

 

 

Question  4.           

Lead-in

Which of the following statements is true?

Option List

A

Pertussis is no longer a significant threat to infants

B

Pertussis remains a significant threat to infants

C

The risk of death from pertussis is eliminated by timely antibiotic therapy

D

the risk of death from pertussis is eliminated by timely antiviral therapy

E

None of the above

Question  5.      

Lead-in

Which of the following statements is true?

Option List

A

Pertussis is not a notifiable disease

B

Pertussis is a notifiable disease

C

Pertussis is not a notifiable disease, but cases should be reported to the local bacteriologist

D

Pertussis is not a notifiable disease, but cases should be subject to audit

Question  6.      

Lead-in

What is the main mode of spread of the organism that causes pertussis?

Option List

A

contact with contaminated surfaces

B

contaminated food

C

contaminated water

D

respiratory droplets

E

none of the above

Question  7.           

Lead-in

What is the main reservoir of the organism that causes pertussis?

Option List

A

budgerigars

B

cats

C

dogs

D

humans

E

pigeons

F

pigs

G

none of the above

Question  8.      

Lead-in

What is the epidemiology of pertussis?

Option List

A

the condition is endemic

B

the condition is endemic with mini-epidemics every 3-5 years

C

the condition is endemic with mini-epidemics most years in the winter months

D

the condition is epidemic, with outbreaks at roughly three-year intervals

E

the condition is epidemic, with outbreaks at unpredictable intervals

Question  9.           

Lead-in

What is the incubation period for pertussis?

Option List

A

3-6     days

B

7-10   days

C

11-14 days

D

15-18 days

E

none of the above.

Question  10.        

Lead-in

What is the duration of infectivity of someone with pertussis?

Option List

A

2 days from exposure → 5 days after onset of paroxysms of coughing

B

3 days from exposure → 10 days after onset of paroxysms of coughing

C

4 days from exposure → 14 days after onset of paroxysms of coughing

D

6 days from exposure → 21 days after onset of paroxysms of coughing

E

none of the above

Question  11.        

Lead-in

What % of non-immune, close contacts of pertussis will develop the disease?

Option List

A

50%

B

60%

C

70%

D

80%

E

90%

Question  12.   

Lead-in

What practical issues are current for obstetrician in relation to pertussis?

Option List

A

The DOH advises that all pregnant women be immunised to maternal death rates.

B

The DOH advises that all pregnant women be immunised to deaths in babies < 3 months.

C

The DOH advises that all babies be immunised at birth.

D

The DOH advised that “Boostrix- IPV should replace “Repevax” from July 2014.

E

The DOH advises that immunisation of pregnant women be continued until 2019

Question  13.        

Lead-in

Which, if any, of the following statements is true in relation to average annual number of deaths due to pertussis in the years before routing child immunisation was introduced?

Option List

A

the number was 10,000

B

the number was    5,000

C

the number was    4,000

D

the number was    3,500

E

the number was <1,000

Question  14.   

Lead-in

Which, if any, of the following statements are true in relation to pertussis vaccine.

Option List

A

“Boostrix- IPV” is a vaccine for pertussis only

B

“Repevax” is a vaccine for pertussis only

C

“Boostrix- IPV” & “Repevax” are live, attenuated vaccines

D

“Boostrix- IPV” & “Repevax” act against diphtheria, tetanus and polio as well as pertussis

E

“Boostrix- IPV” & “Repevax” are acellular

Question  15.   

Lead-in

Which, if any, of the following statements are true in relation to the JCVI’s advice of the best time to administer pertussis vaccine in pregnancy?

Option List

A

20 - 24 weeks

B

25- 28 weeks

C

28 - 32 weeks

D

28 - 34 weeks

E

none of the above

Question  16.        

Lead-in

A woman has suspected pertussis in early pregnancy. Should she still be offered vaccination?

Option List

A

Yes

B

No

C

I don’t know

D

I don’t know

E

I hate this subject now

Question  17.        

Lead-in

A woman has proven pertussis in early pregnancy. Should she still be offered vaccination?

Option List

A

Yes

B

No

C

I don’t know

D

I don’t know

E

I hate this subject now

Question  18.        

Lead-in

A pregnant woman misses out on vaccination as part of the TIPP. Should vaccination still be offered in the puerperium?

Option List

A

Yes

B

No

C

I don’t know

D

I don’t know

E

I hate this subject now

 

 

 

 


No comments:

Post a Comment